InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
4
Disclosed sells
3
T+90 hit rate
56%
T+90 mean return
+7.1%
Across 18 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Bush Tia L, Directeur Qualité. Officer active across 1 company, notably Centessa Pharmaceuticals plc. In total, 22 disclosures have been recorded. Breakdown: 4 buys · 3 sells. Total volume traded: €299k. Activity tracked since 2 June 2021. The latest transaction was filed on 1 February 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Declarations22 total
147,954 sharesOrdinary SharesSEC:0001470831-26-000621:0
8,693 shares@ US$16.9215.3% of flowOrdinary SharesSEC:0001847903-25-000023:0
6,419 shares@ US$16.3510.9% of flowOrdinary SharesSEC:0001847903-24-000198:0
9,611 shares@ US$16.362116.2% of flowOrdinary SharesSEC:0001847903-24-000184:0
6,419 shares@ US$15.799.9% of flowOrdinary SharesSEC:0001847903-24-000153:0
6,419 shares@ US$9.035.9% of flowOrdinary SharesSEC:0001847903-24-000115:0
6,419 shares@ US$11.307.3% of flowOrdinary SharesSEC:0001847903-24-000060:0
42,500 shares0Ordinary SharesSEC:0001847903-24-000032:0
6,419 shares@ US$7.965.0% of flowOrdinary SharesSEC:0001847903-24-000009:0
6,419 shares@ US$6.474.3% of flowOrdinary SharesSEC:0001847903-23-000169:0
6,419 shares@ US$5.90013.8% of flowOrdinary SharesSEC:0001847903-23-000141:0
5,000 shares@ US$4.4852.3% of flowOrdinary SharesSEC:0001847903-23-000102:0
4,319 shares@ US$3.901.7% of flowOrdinary SharesSEC:0001847903-23-000080:0
30,200 shares0Ordinary SharesSEC:0001847903-23-000044:0
5,765 shares@ US$4.252.7% of flowOrdinary SharesSEC:0001847903-23-000024:0
3,014 shares@ US$3.100.9% of flowOrdinary SharesSEC:0001847903-23-000009:0
2,118 shares@ US$4.06740.9% of flowOrdinary SharesSEC:0001847903-22-000062:0
140,000 shares0Ordinary SharesSEC:0000899243-22-025473:0
995 shares@ US$12.101.1% of flowOrdinary SharesSEC:0000899243-21-045312
Ideal exit: 13 Aug 2022 (T+270)
995 shares@ US$12.100.0002% mcap8.9% of flowOrdinary SharesSEC:0000899243-21-045312:0
Ideal exit: 13 Aug 2022 (T+270)
3,000 shares@ US$20.000.0008% mcap41.1% of flowOrdinary SharesSEC:0000899243-21-022069:0
Ideal exit: 27 Feb 2022 (T+270)
3,000 shares@ US$20.005.3% of flowOrdinary SharesSEC:0000899243-21-022069
Ideal exit: 27 Feb 2022 (T+270)
22 of 22 declarations
About Bush Tia L
Tia L. Bush is the Chief Quality Officer at Centessa Pharmaceuticals plc. She is responsible for managing product quality and compliance. Bush plays a crucial role in quality assurance and continuous improvement.
